Twin study shows MS is more nurture than nature
29 April, 2010 by Tim DeanMonozygotic - or identical - twins have provided science with the ideal platform for distinguishing between genetic and environmental influences for anything from personality, risk of cardiovascular disease or even voting habits.
Link between weight loss and immune function
20 April, 2010 by Tim DeanOver half the Australian population is either overweight or obese, with many experiencing corresponding health effects, such as cardiovascular disease and Type 2 diabetes.
Global cancer genome project releases first data
15 April, 2010 by Tim DeanAustralian researchers release initial pancreatic cancer genomes as part of the International Cancer Genome Consortium.
Gene linked to breast cancer survival
14 April, 2010 by Tim DeanA gene associated with eye colour and skin pigmentation has been linked to survival rates in breast cancer patients.
Breast cancer linked to stem cells
12 April, 2010 by Tim DeanThe mechanism linking breast cancer to stem cells has been uncovered, which could lead to new cancer treatments.
Potential new Alzheimer's drugs advancing in clinical trials
08 April, 2010 by Staff WritersThe hypothesis that amyloid-beta blockers is the cause of Alzheimer's disease is being put to the test.
Phosphagenics goes global
31 March, 2010 by Staff WritersPhosphagenics signs global agreement for use of transdermal insulin in pets.
Insight in to insulin could lead to new diabetes treatment
24 March, 2010 by Tim DeanStructure of a previously unseen part of the insulin receptor has been revealed by WEHI scientists.
Coeliac disease related to diabetes
22 March, 2010 by Staff WritersAn international research team has identified new gene variants associated with gluten intolerance.
Positive results for Specialised Therapeutics Australia in lung cancer trial
18 March, 2010 by Tim DeanPhase III trial shows breast cancer drug, Abraxane, effective against lung cancer.
Personalised medicine advanced with TGA approval of bowel cancer treatment
10 March, 2010 by Tim DeanMetastatic bowel cancer treatment, Erbitux, is one of the new generation of highly effective personalised medicine therapies.
Diabetes market growing, obesity market shrinking: analysts
10 March, 2010 by Tim DeanDatamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.
Link found between Hepatitis C and diabetes
09 March, 2010 by Staff WritersResearchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes.
Feature: Appetite for NPY
01 March, 2010 by Tim DeanA better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.
Epilepsy, aging and malaria research big winners in 2010 NHMRC grants
25 February, 2010 by Staff Writers$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering.
